These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1490649)

  • 1. Potassium channel openers: pharmacological and clinical aspects.
    Quast U
    Fundam Clin Pharmacol; 1992; 6(7):279-93. PubMed ID: 1490649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do the K+ channel openers relax smooth muscle by opening K+ channels?
    Quast U
    Trends Pharmacol Sci; 1993 Sep; 14(9):332-7. PubMed ID: 8249154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
    Yanagisawa T; Teshigawara T; Taira N
    Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
    Garrino MG; Plant TD; Henquin JC
    Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
    Satoh H
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):863-8. PubMed ID: 7509906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.
    Nagai H; Kitagaki K; Goto S; Suda H; Koda A
    Jpn J Pharmacol; 1991 May; 56(1):13-21. PubMed ID: 1831870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle.
    Satoh E; Yanagisawa T; Taira N
    Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of potassium channel openers.
    Andersson KE
    Pharmacol Toxicol; 1992 Apr; 70(4):244-54. PubMed ID: 1535127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA; Stork AP
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
    Wilson C; Coldwell MC; Howlett DR; Cooper SM; Hamilton TC
    Eur J Pharmacol; 1988 Aug; 152(3):331-9. PubMed ID: 2851450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channel opening drugs and the airways.
    Small RC; Berry JL; Foster RW
    Braz J Med Biol Res; 1992; 25(10):983-98. PubMed ID: 1342832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of nicorandil by 86Rb efflux and isometric vasorelaxation studies in vascular smooth muscle.
    Kreye VA; Lenz T; Pfründer D; Theiss U
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S8-12. PubMed ID: 1282181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro effects of K+ channel modulators on detrusor and portal vein strips from guinea pigs.
    Zografos P; Li JH; Kau ST
    Pharmacology; 1992; 45(4):216-30. PubMed ID: 1438528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of putative activators of K+ channels on pancreatic B-cell function.
    Plant TD; Garrino MG; Henquin JC
    Pflugers Arch; 1989; 414 Suppl 1():S152-3. PubMed ID: 2528721
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.
    Yoneyama F; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1119-26. PubMed ID: 2150593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
    Kamijo T; Tomaru T; Miwa A; Nakamura F; Kido H; Sugimoto T; Uchida Y
    Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):317-27. PubMed ID: 1446882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potassium channel openers: a new class of vasorelaxants.
    Weston AH; Longmore J; Newgreen DT; Edwards G; Bray KM; Duty S
    Blood Vessels; 1990; 27(2-5):306-13. PubMed ID: 1700735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological properties of ATP-sensitive K+ channels in mammalian skeletal muscle cells.
    Allard B; Lazdunski M
    Eur J Pharmacol; 1993 Jun; 236(3):419-26. PubMed ID: 8359200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.